Latest Australian Securities Exchange News

Spenda Limited's SPXOB securities have been suspended from trading by the ASX due to non-compliance with listing requirements. The suspension affects only this security class, leaving other Spenda securities unaffected.

Brightstar Resources is progressing construction at its Goldfields Project on time and budget, targeting first gold by June 2027 while securing gold price downside protection through put options.

The Munro Climate Change Leaders Fund Active ETF (ASX: MCCL) has announced a final distribution of 298.916141 cents per unit for the year ending 30 June 2026, slightly below last year's payout. Key dates for investors include an ex-distribution date of 1 July and a payment date of 22 July.

JPMorgan Asset Management has released updated estimated annual cash distributions for six of its ASX-listed ETFs for the financial year ending 30 June 2026, with amounts varying widely between funds and one yielding no distribution.

JPMorgan Asset Management (Australia) Limited has announced final cash distributions for June 2026 across three of its Equity Premium Income ETFs, detailing payment amounts, reinvestment prices, and key dates for investors.

Vanguard Investments Australia has released estimated distribution amounts for 34 ETFs, covering a broad spectrum of asset classes, with payments scheduled for mid-July 2026.

Cluey Ltd has formally requested voluntary delisting from the ASX, with the exchange agreeing in principle subject to shareholder approval and regulatory conditions. A general meeting is scheduled for 13 August 2026 to vote on the proposal.

Global X Management (AUS) Limited has announced estimated distributions for over 30 ETFs for the period ending 30 June 2026, all eligible for reinvestment via its Distribution Reinvestment Plan (DRP). The announcement outlines key dates for investors to act on their DRP elections and highlights the wide range of income levels across its funds.

SIV Capital has been advised by the ASX of a significant risk that it will fail to meet key listing requirements, prompting the company to explore alternative paths forward.

Cluey Ltd plans to voluntarily delist from the ASX, citing thin trading volumes, undervaluation, and cost savings of around A$500,000 annually. Shareholders will vote on the proposal in August 2026, alongside a small parcel buy-back and the closure of its UK subsidiary Code Camp.

SDI Limited shareholders voted overwhelmingly in favour of a $1.40 per share acquisition scheme by InnoXvest Dental, setting the stage for court approval and delisting.

Cynata Therapeutics (ASX: CYP) has had its trading suspension lifted immediately following the publication of results from its Phase 3 Osteoarthritis and Phase 2 Graft versus Host Disease clinical trials.